# Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study

> **NCT00263705** · PHASE2 · COMPLETED · sponsor: **Jules Bordet Institute** · enrollment: 43 (actual)

## Conditions studied

- Elderly Patients
- Breast Cancer

## Interventions

- **DRUG:** Adjuvant capecitabine
- **DRUG:** capecitabine in aduvant setting

## Key facts

- **NCT ID:** NCT00263705
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263705, "Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00263705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*